HealthTech
Singapore’s biotechnology firm K2 Therapeutics raises $50M in seed financing from MPM BioImpact
K2 Therapeutics, a Singapore-based biotechnology company, has raised $50 million in seed financing from MPM BioImpact, the U.S. investment firm that founded the company in 2024.
China’s Ant Group upgrades physician platform into AI workstation “AQ for Doctor” with 300,000 verified doctors
China's Ant Group, the operator of Alipay, has upgraded its physician platform "Haodf for Doctor" into "AQ for Doctor," an AI-powered workstation for physicians covering online consultations, patient management, clinical decision support, and medical research.
The widening gap between healthcare digitization announcements and actual deployment in Asia
Asia is seeing a wave of digital health announcements, from AI diagnostics to telehealth platforms. Yet the pace of actual deployment remains uneven. Amit Yadav looks at the infrastructure and market signals that can help investors, healthcare operators, and policymakers distinguish experimentation from adoption at scale.
Japan Investment Corporation commits $12.7M to VC fund Red No. 1 Healthcare
Japan Investment Corporation (JIC) will invest JPY2 billion ($12.7 million) in Red No. 1 Healthcare Investment Limited Partnership, which focuses on biotech, medical devices, and healthcare services startups.
Malaysia’s Qmed Asia, Intel to jointly build unified hospital patient monitoring platform
Malaysia's Qmed Asia and United States chipmaker Intel will cooperate to develop a unified patient monitoring platform for hospitals, combining Intel's Patient Monitoring Hub Reference Implementation with Qmed Asia's healthcare software to consolidate fragmented bedside data into a centralized Smart Ward dashboard.
Why elder care’s next phase is about AI-native devices, not just connected hardware
Connected hardware helped establish the foundation for digital elder care. The next phase will depend on AI-native devices that can understand context, respond conversationally, and support older adults and caregivers in real time.
Ant Group takes 28% stake in China’s Boohee Health as AI health app AQ surpasses 100M users
Ant Group has completed a strategic investment in Boohee Health, becoming its largest external shareholder with a stake of over 28 percent, as the two companies deepen cooperation in weight management and AI-driven health services.
Asia Pacific medtech demand to reach $132B by 2030, only few companies achieve global scale: Bain report
Asia Pacific's share of global medtech demand is expected to reach $132 billion by 2030, growing at 6.9 percent annually and faster than the global market, according to a new report by Bain & Company.
Singapore’s Biobot Surgical raises $15M to expand robotic prostate cancer platform into US market
Biobot Surgical, a Singapore-based medical technology company developing robotic-assisted systems for prostate cancer diagnosis and treatment, has secured S$20 million ($15.4 million) in its latest financing round led by ClavystBio in partnership with ZIG Ventures.
Healthcare firm Vinmec launches Vietnam’s first multi-connected robotic surgery network
Vinmec Healthcare System, under Vietnam's conglomerate Vingroup, has launched a nationwide network of High-Tech Robotic Surgery Centers, establishing Vietnam's first multi-connected robotic surgery ecosystem that links multiple robotic technologies across its hospital network.
